RonanRx launches personalized GLP-1 plans with doctor-set dosing and pharmacist oversight

Launch HN: RonanRX (YC S26) – Personalized Peptides and GLP-1s

RonanRx, a Y Combinator-backed startup, offers personalized GLP-1 care where physicians set doses and titration schedules based on individual history, and licensed pharmacists control release. The service includes patient-specific adjuncts like B12 for tolerability, with a fail-closed chain of custody ensuring safety. Compounded medications may cost less than brand-name GLP-1s, and the company emphasizes transparency and physician authority.